Page 18 - IMO-2-3
P. 18

Innovative Medicines & Omics                              MSC exosomes for digestive tumors: Bench to bedside



               Annu Rev Pathol. 2022;18:123-148.                  disorders. J Extracell Vesicles. 2023;12:e12361.
               doi: 10.1146/annurev-pathmechdis-031621-024600     doi: 10.1002/jev2.12361
            55.  Kumarasamy V, Wang J, Frangou C, et al. The extracellular   64.  Levy D, Jeyaram A, Born LJ,  et al. Impact of storage
               niche  and  tumor  microenvironment  enhance  KRAS   conditions and duration on function of native and cargo-
               inhibitor  efficacy  in  pancreatic  cancer.  Cancer Res.   loaded  mesenchymal  stromal  cell  extracellular  vesicles.
               2024;84:1115-1132.                                 Cytotherapy. 2022;25:502-509.
               doi: 10.1158/0008-5472.CAN-23-2504                 doi: 10.1016/j.jcyt.2022.11.006
            56.  Parte S, Kaur AB, Nimmakayala RK, et al. Cancer-associated   65.  Wang S, Leu B, Zhang E,  et al. Targeted therapy for
               fibroblast induces acinar-to-ductal cell transdifferentiation   inflammatory  diseases  with  mesenchymal  stem  cells
               and pancreatic cancer initiation Via LAMA5/ITGA4 axis.   and their derived exosomes: from basic to clinics.  Int J
               Gastroenterology. 2023;166:842-858.e5.             Nanomedicine. 2022;17:1757-1781.
               doi: 10.1053/j.gastro.2023.12.018                  doi: 10.2147/IJN.S355366
            57.  Zhou Y, Zhou W, Chen X, et al. Bone marrow mesenchymal   66.  Zhang L, Ma XJ, Fei YY,  et al. Stem cell therapy in liver
               stem cells-derived exosomes for penetrating and targeted   regeneration: Focus on mesenchymal stem cells and induced
               chemotherapy of pancreatic cancer.  Acta Pharm Sin B.   pluripotent stem cells. Pharmacol Ther. 2021;232:108004.
               2020;10:1563-1575.                                 doi: 10.1016/j.pharmthera.2021.108004
               doi: 10.1016/j.apsb.2019.11.013                 67.  Zhang J, Guan J, Niu X, et al. Exosomes released from human
            58.  Zhou W, Zhou Y, Chen X,  et al. Pancreatic cancer-  induced pluripotent stem cells-derived MSCs facilitate
               targeting  exosomes  for  enhancing  immunotherapy  and   cutaneous wound healing by promoting collagen synthesis
               reprogramming tumor microenvironment.  Biomaterials.   and angiogenesis. J Transl Med. 2015;13:49.
               2020;268:120546.                                   doi: 10.1186/s12967-015-0417-0
               doi: 10.1016/j.biomaterials.2020.120546         68.  Kim S, Lee SK, Kim H, Kim TM. Exosomes secreted from
            59.  He Z, Li W, Zheng T, Liu D, Zhao S. Human umbilical   induced pluripotent stem cell-derived mesenchymal
               cord mesenchymal stem cells-derived exosomes deliver   stem cells accelerate skin cell proliferation.  Int J Mol Sci.
               microRNA-375 to downregulate ENAH and thus retard   2018;19:3119.
               esophageal squamous cell carcinoma progression. J Exp Clin      doi: 10.3390/ijms19103119
               Cancer Res. 2020;39:59.
                                                               69.  Wei Y, Hou H, Zhang L, et al. JNKi-and DAC-programmed
               doi: 10.1186/s13046-020-01631-w                    mesenchymal stem/stromal cells from hESCs facilitate
            60.  Li N, Wang B. Suppressive effects of umbilical cord   hematopoiesis and alleviate hind limb ischemia. Stem Cell
               mesenchymal stem cell-derived exosomal miR-15a-5p   Res Ther. 2019;10:186.
               on the progression of cholangiocarcinoma by inhibiting      doi: 10.1186/s13287-019-1302-1
               CHEK1 expression. Cell Death Discov. 2022;8:205.
                                                               70.  Zhou H, Zhu L, Song J, et al. Liquid biopsy at the frontier
               doi: 10.1038/s41420-022-00932-7                    of  detection,  prognosis  and progression  monitoring  in
            61.  Zou J, Yang W, Cui W,  et al. Therapeutic potential   colorectal cancer. Mol Cancer. 2022;21:86.
               and mechanisms of mesenchymal stem cell-derived      doi: 10.1186/s12943-022-01556-2
               exosomes as bioactive materials in tendon-bone healing.
               J Nanobiotechnol. 2023;21:14.                   71.  Xia Y, Sun Y, Liu Y, et al. Targeted delivery of RGD-CD146(+)
                                                                  CD271(+) human umbilical cord mesenchymal stem cell-
               doi: 10.1186/s12951-023-01778-6                    derived exosomes promotes blood-spinal cord barrier repair
                                                                  after spinal cord injury. ACS Nano. 2023;17:18008-18024.
            62.  Popowski K, Lutz H, Hu S,  et al. Exosome therapeutics
               for lung regenerative medicine.  J  Extracell Vesicles.      doi: 10.1021/acsnano.3c04423
               2020;9:1785161.
                                                               72.  Phan J, Kumar P, Hao D, Gao K, Farmer D, Wang A.
               doi: 10.1080/20013078.2020.1785161                 Engineering mesenchymal stem cells to improve their
                                                                  exosome efficacy and yield for cell-free therapy. J Extracell
            63.  Huang  R,  Bo  Jia  2,  Dandan  Su,  et al.  Plant  exosomes
               fused with engineered mesenchymal stem cell-derived   Vesicles. 2018;7(1):1522236.
               nanovesicles for synergistic therapy of autoimmune skin      doi: 10.1080/20013078.2018.1522236







            Volume 2 Issue 3 (2025)                         12                          doi: 10.36922/IMO025210025
   13   14   15   16   17   18   19   20   21   22   23